BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Miskulin DC, Weiner DE, Tighiouart H, Lacson EK Jr, Meyer KB, Dad T, Manley HJ. High-Dose Seasonal Influenza Vaccine in Patients Undergoing Dialysis. Clin J Am Soc Nephrol 2018;13:1703-11. [PMID: 30352787 DOI: 10.2215/CJN.03390318] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Aznab M, Eskandari Roozbahani N, Moazen H. Value of influenza vaccines in cancer patients during the coronavirus (COVID-19) pandemic: a cross-sectional study. Support Care Cancer 2021. [PMID: 33837848 DOI: 10.1007/s00520-021-06204-x] [Reference Citation Analysis]
2 Khan SF, Bowman BT. Vaccinating the Patient with ESKD. Clin J Am Soc Nephrol 2019;14:1525-7. [PMID: 31262770 DOI: 10.2215/CJN.02210219] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
3 Butler AM, Layton JB, Dharnidharka VR, Sahrmann JM, Seamans MJ, Weber DJ, McGrath LJ. Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccine Among Patients Receiving Maintenance Hemodialysis. Am J Kidney Dis 2020;75:72-83. [PMID: 31378646 DOI: 10.1053/j.ajkd.2019.05.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
4 Hu PJ, Chen CH, Wong CS, Chen TT, Wu MY, Sung LC. Influenza vaccination reduces incidence of peripheral arterial occlusive disease in elderly patients with chronic kidney disease. Sci Rep 2021;11:4847. [PMID: 33649465 DOI: 10.1038/s41598-021-84285-8] [Reference Citation Analysis]
5 Manley HJ, Lacson EK, Aweh G, Li NC, Weiner DE, Miskulin DC, Hsu CM, Kapoian T, Hayney MS, Meyer KB, Johnson DS. Seroresponse to Inactivated and Recombinant Influenza Vaccines Among Maintenance Hemodialysis Patients. American Journal of Kidney Diseases 2022. [DOI: 10.1053/j.ajkd.2022.01.425] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Chang YT, Ling TC, Cheng YY, Sun CY, Wu JL, Tai CH, Wang JR, Sung JM. Comparison of Immunogenicity and Safety between a Single Dose and One Booster Trivalent Inactivated Influenza Vaccination in Patients with Chronic Kidney Disease: A 20-Week, Open-Label Trial. Vaccines (Basel) 2021;9:192. [PMID: 33669067 DOI: 10.3390/vaccines9030192] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Jahn M, Korth J, Dorsch O, Anastasiou OE, Krawczyk A, Brochhagen L, van de Sand L, Sorge-hädicke B, Tyczynski B, Witzke O, Dittmer U, Dolff S, Wilde B, Kribben A. Decline of Humoral Responses 6 Months after Vaccination with BNT162b2 (Pfizer–BioNTech) in Patients on Hemodialysis. Vaccines 2022;10:327. [DOI: 10.3390/vaccines10020327] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Barbar T, Tummalapalli SL, Silberzweig J. Influenza Vaccines in Maintenance Hemodialysis Patients: Does Seroresponse Vary With Different Vaccine Formulations? Am J Kidney Dis 2022:S0272-6386(22)00552-2. [PMID: 35637062 DOI: 10.1053/j.ajkd.2022.02.014] [Reference Citation Analysis]
9 Layton JB, McGrath LJ, Sahrmann JM, Ma Y, Dharnidharka VR, O'Neil C, Weber DJ, Butler AM. Comparative safety of high-dose versus standard-dose influenza vaccination in patients with end-stage renal disease. Vaccine 2020;38:5178-86. [PMID: 32565346 DOI: 10.1016/j.vaccine.2020.06.020] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Lindley MC, Kim DK. Increasing Protection of Dialysis Patients against Influenza. Clin J Am Soc Nephrol 2018;13:1624-6. [PMID: 30352786 DOI: 10.2215/CJN.11670918] [Reference Citation Analysis]
11 Jacq A, Rebibou JM, Kohler E, Baudoin C, Bour JB, De Rougemont A, Marechal E, Legendre M. Normalized protein catabolic rate and lymphopenia drive humoral response to the Pfizer BNT162b2 vaccine in haemodialysis patients. Nephrol Dial Transplant 2021;36:2140-2. [PMID: 34383943 DOI: 10.1093/ndt/gfab241] [Reference Citation Analysis]